<div id="readability-page-1"><p>Corient Private Wealth LLC lowered its holdings in shares of  Lam Research Corporation (NASDAQ:LRCX - Free Report) by 1.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor  owned 1,823,595 shares of the semiconductor company's stock after selling 20,865 shares during the quarter. Corient Private Wealth LLC owned about 0.14% of Lam Research worth $177,511,000 as of its most recent filing with the Securities and Exchange Commission.</p><ul><li>The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains</li></ul><p>A number of other large investors have also recently bought and sold shares of LRCX. IMG Wealth Management Inc. acquired a new position in  Lam Research during the second quarter valued at approximately $26,000.  Howard Hughes Medical Institute bought a new stake in shares of  Lam Research during the 2nd quarter worth $27,000.  Strategic Wealth Investment Group LLC acquired a new position in  Lam Research in the 2nd quarter valued at $29,000.  Delos Wealth Advisors LLC bought a new position in  Lam Research in the 2nd quarter worth $30,000.  Finally, REAP Financial Group LLC acquired a new position in  Lam Research during the 2nd quarter worth $31,000. 84.61% of the stock is currently owned by institutional investors. </p><h2>Lam Research Price Performance</h2><p>Shares of LRCX stock opened at $160.52 on Monday. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $169.69. The company has a market capitalization of $201.62 billion, a P/E ratio of 35.36, a P/E/G ratio of 1.65 and a beta of 1.77. The stock has a 50 day moving average of $152.53 and a two-hundred day moving average of $120.50. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. </p><ul><li>Applied Materials: Up 40% in 2025 With Room to Run Long-Term</li></ul><p>Lam Research (NASDAQ:LRCX - Get Free Report) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, beating analysts' consensus estimates of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. During the same period in the prior year, the company posted $0.86 earnings per share. Lam Research's revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS.  As a group, equities analysts expect that  Lam Research Corporation will post 3.71 EPS for the current year. </p><h2>Lam Research Announces Dividend</h2><p>The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be paid a $0.26 dividend. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a yield of 0.6%. Lam Research's payout ratio is presently 22.91%. </p><h2>Insider Buying and Selling at Lam Research</h2><ul><li>MarketBeat Week in Review – 11/10 - 11/14</li></ul><p>In other news, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the transaction, the chief financial officer directly owned 987,237 shares of the company's stock, valued at approximately $148,677,892.20. This represents a 3.90% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Vahid Vahedi sold 52,190 shares of the firm's stock in a transaction that occurred on Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the transaction, the senior vice president owned 251,047 shares of the company's stock, valued at $34,870,428.30. This trade represents a 17.21% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 102,608 shares of company stock worth $14,916,496. 0.31% of the stock is currently owned by company insiders. </p><h2>Wall Street Analyst Weigh In</h2><p>Several equities research analysts have recently issued reports on LRCX shares. Evercore ISI raised their price target on Lam Research from $115.00 to $170.00 and gave the company an &#34;outperform&#34; rating in a research report on Thursday, October 23rd. Dbs Bank increased their target price on Lam Research from $119.40 to $184.20 in a research note on Monday, October 27th. Cowen  reaffirmed a &#34;buy&#34; rating on shares of Lam Research in a report on Thursday, October 23rd. Needham &amp; Company LLC lifted their price target on Lam Research from $150.00 to $160.00 and gave the stock a &#34;buy&#34; rating in a research report on Thursday, October 23rd. Finally, Barclays  set a $142.00 price objective on Lam Research and gave the company an &#34;equal weight&#34; rating in a research report on Monday, October 20th. Twenty-six research analysts have rated the stock with a Buy rating and ten have issued  a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of &#34;Moderate Buy&#34; and an average target price of $152.87.</p><p><b>Read Our Latest Stock Analysis on LRCX</b></p><h2>Lam Research Profile</h2> (Free Report)<p>Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Lam Research</li><li>How to Calculate Return on Investment (ROI)</li><li>Dave &amp; Buster’s Reversal Is in PLAY After Double-Bottom Breakout</li><li>How to buy stock: A step-by-step guide for beginners </li><li>3 Finance Stocks to Buy on Rising 10-Year Treasury Rates</li><li>The Risks of Owning Bonds</li><li>Disney's $1 Billion Deal Brings Its Magic to OpenAI</li></ul><p><strong>Want to see what other hedge funds are holding LRCX?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TFJDWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TFJDWA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Lam Research Right Now?</h2><p>Before you consider Lam Research, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.</p><p>While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

LRCX

<p>Corient Private Wealth LLC reduced its stake in Lam Research Corporation by 1.1% in Q2, selling 20,865 shares. Lam Research's stock opened at $160.52, with a 12-month high of $169.69. The company reported Q2 earnings of $1.26 per share, beating estimates. Analysts raised price targets, with Evercore ISI setting it at $170.00. Lam Research announced a quarterly dividend of $0.26 per share.</p>

Corient Private Wealth LLC Sells 20,865 Shares of Lam Research Corporation $LRCX